We just received data on a new analyst forecast for $NTRA. Evercore ISI Group gave a rating of 'Outperform' for $NTRA.
$NTRA Analyst Ratings
Wall Street analysts have issued reports on $NTRA in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI Group issued a "Outperform" rating on 07/28/2025
- Piper Sandler issued a "Overweight" rating on 05/15/2025
- UBS issued a "Buy" rating on 05/09/2025
- Barclays issued a "Overweight" rating on 05/09/2025
- RBC Capital issued a "Outperform" rating on 03/13/2025
- Morgan Stanley issued a "Overweight" rating on 03/05/2025
- Canaccord Genuity issued a "Buy" rating on 02/28/2025
To track analyst ratings and price targets for $NTRA, check out Quiver Quantitative's $NTRA forecast page.
$NTRA Price Targets
Multiple analysts have issued price targets for $NTRA recently. We have seen 8 analysts offer price targets for $NTRA in the last 6 months, with a median target of $192.5.
Here are some recent targets:
- Daniel Markowitz from Evercore ISI Group set a target price of $170.0 on 07/28/2025
- David Westenberg from Piper Sandler set a target price of $210.0 on 05/15/2025
- Elizabeth Garcia from UBS set a target price of $218.0 on 05/09/2025
- Luke Sergott from Barclays set a target price of $190.0 on 05/09/2025
- Conor McNamara from RBC Capital set a target price of $251.0 on 03/13/2025
- Tejas Savant from Morgan Stanley set a target price of $185.0 on 03/05/2025
- Kyle Mikson from Canaccord Genuity set a target price of $195.0 on 02/28/2025
$NTRA Insider Trading Activity
$NTRA insiders have traded $NTRA stock on the open market 228 times in the past 6 months. Of those trades, 0 have been purchases and 228 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has made 0 purchases and 31 sales selling 161,043 shares for an estimated $23,630,208.
- MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) has made 0 purchases and 16 sales selling 112,848 shares for an estimated $17,191,147.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 32 sales selling 65,525 shares for an estimated $11,094,357.
- JONATHAN SHEENA has made 0 purchases and 74 sales selling 37,696 shares for an estimated $5,808,052.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has made 0 purchases and 14 sales selling 29,940 shares for an estimated $4,952,256.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has made 0 purchases and 30 sales selling 30,301 shares for an estimated $4,683,655.
- GAIL BOXER MARCUS has made 0 purchases and 20 sales selling 20,299 shares for an estimated $3,137,557.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has made 0 purchases and 11 sales selling 9,317 shares for an estimated $1,485,187.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NTRA Hedge Fund Activity
We have seen 330 institutional investors add shares of $NTRA stock to their portfolio, and 309 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,795,315 shares (+56.3%) to their portfolio in Q1 2025, for an estimated $536,695,494
- BLACKROCK, INC. added 1,260,125 shares (+13.7%) to their portfolio in Q1 2025, for an estimated $178,194,276
- KYNAM CAPITAL MANAGEMENT, LP removed 854,528 shares (-42.3%) from their portfolio in Q1 2025, for an estimated $120,838,804
- GOLDMAN SACHS GROUP INC removed 734,551 shares (-43.3%) from their portfolio in Q1 2025, for an estimated $103,872,856
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 732,156 shares (+140.4%) to their portfolio in Q1 2025, for an estimated $103,534,179
- CITADEL ADVISORS LLC added 691,990 shares (+48.4%) to their portfolio in Q1 2025, for an estimated $97,854,305
- JPMORGAN CHASE & CO added 660,538 shares (+9.9%) to their portfolio in Q1 2025, for an estimated $93,406,678
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
